Lead Edge Growth Opportunities Ltd. (LEGA) Prices 30M Unit IPO at $10/Unit
- Wall Street ends week positively; S&P 500, Dow hit record highs
- Bitcoin (BTC) Drops 3% as Turkey Bans Cryptocurrency Payments Citing Lack of Regulatory Supervision
- Morgan Stanley (MS) Archegos-Related Loss Appears to be $911M
- Dollar at 4-week low on retreating Treasury yields
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
Lead Edge Growth Opportunities, Ltd (NASDAQ: LEGA), a special purpose acquisition company formed for the purpose of entering into a combination with one or more businesses, today announced the pricing of its initial public offering of 30,000,000 units at a price of $10.00 per unit. The units will be listed on The Nasdaq Capital Market (“Nasdaq”) and will trade under the ticker symbol “LEGAU” beginning on March 23, 2021. Each unit consists of one Class A ordinary share of the Company and one-fourth of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share of the Company at a price of $11.50 per share. Only whole warrants are exercisable. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “LEGA” and “LEGAW,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The offering is expected to close on March 25, 2021, subject to customary closing conditions.
The Company, which will be led by its Chairman and Chief Executive Officer, Mitchell H. Green, will pursue opportunities with high-quality software, Internet and technology-enabled companies. The Company’s sponsor is an affiliate of Lead Edge Capital Management, LLC, a growth equity investment firm based in New York, New York and Santa Barbara, California.
Credit Suisse Securities (USA) LLC and J.P. Morgan Securities LLC are serving as joint book-running managers for this offering. The Company has granted the underwriters a 45-day option to purchase up to an additional 4,500,000 units to cover over-allotments, if any.
The offering is being made only by means of a prospectus.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Recursion Pharmaceuticals Inc. (RXRX) IPO Opens 67% Higher
- Diversey Announces Exercise of Underwriters’ Option to Purchase Additional Shares
- IPO for Autonomous Trucking Player TuSimple (TSP) Opens Flat